Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
Research interests: bionanotechnology, mechanistic enzymology; recombinant DNA and biophysical methods; medicinal chemistry and molecular modeling
Professor John Honek developed novel amino acid analogs used to investigate protein structure/function and control metalloenzyme activity and uniquely applies biological chemistry to areas of nanotechnology such as bioencapsulation and biomaterial interfaces.
The Honek Lab, operating within the University of Waterloo Chemistry department, works at the interface of chemistry and biochemistry. Group members apply chemical and biochemical principles and techniques to the problems of protein structure/function as well as to elucidate the chemical mechanisms of several key enzymes, some of which have medical importance.
Honek received his BSc (Honours Chemistry) from McGill University in 1977, and obtained his PhD (Chemistry) in 1984 also from McGill University under the direction of the late Professor Bernard Belleau, one of the discoverers of the anti-AIDS drug 3TC. Honek took up FCAC (Québec) and Natural Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowships to continue his studies (1984, 1985) under the direction of Professor Christopher Walsh at Massachusetts Institute of Technology (MIT), U.S.A., where he worked on the biochemistry of biogenic methane production. Honek joined the University of Waterloo Chemistry department in 1986 and held the role of Chemistry Department Chair from 2007 to 2014.
Professor Honek is on the editorial board of several journals including:
Cross-appointed to UW Pharmacy
Postdoctoral Fellow: Massachusetts Institute of Technology
PhD, Chemistry, McGill University, 1984
BSc, Chemistry, McGill University, 1977
Year | Awards and Honours |
---|---|
2014 | Canadian Society for Chemistry (CSC) Bernard Belleau Award, sponsored by Vertex Pharmaceuticals (Canada) Inc. |
Professor Honek’s interest is to understand the fundamental interactions of small molecules (such as substrates and drugs) with enzymes as well as the mechanisms by which enzymes catalyze reactions. Research in this area includes mechanistic enzymology, recombinant DNA and biophysical methods as well as organic synthesis, medicinal chemistry and molecular modeling. An additional focus is in the area of bionanotechnology and the application of biological chemistry to the synthesis of new nanomaterials and nanostructures.
Knowledge of an enzyme’s catalytic mechanism can be of fundamental importance as well as a critical factor in the design and synthesis of inhibitors having therapeutic potential. The group is currently focused on the biological chemistry of the carbon-sulfur bond as it relates to the amino acid methionine and its biochemical function in proteins as well as the study of the enzyme glyoxalase I, a detoxification metalloenzyme that utilizes a sulfur-containing cofactor, glutathione.
Two areas are of current interest. The first is the investigation of extremely large multisubunit proteins which contain internal cavities. These nanosized proteins may be useful as novel drug carriers and as molecular foundations for nanodevices. The second area is the study of the molecular level interactions between biomolecules and nanomaterials. We have utilized phage display methods and unnatural amino acid incorporation techniques to identify peptide sequences that have strong affinity to single-walled carbon nanotubes.
Biochemistry
Bioorganic/biological chemistry
Medicinal chemistry
Bionanotechnology
Recent publications include:
Office: ESC 246
Phone: 519-888-4567, ext.35817
Email: jhonek@uwaterloo.ca
Personal Website: John Honek
Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
The University of Waterloo acknowledges that much of our work takes place on the traditional territory of the Neutral, Anishinaabeg and Haudenosaunee peoples. Our main campus is situated on the Haldimand Tract, the land granted to the Six Nations that includes six miles on each side of the Grand River. Our active work toward reconciliation takes place across our campuses through research, learning, teaching, and community building, and is centralized within our Office of Indigenous Relations.